Next Phase Newsletter

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

During Covid, Life Science Nation (LSN) changed the partnering landscape and emphatically proved that virtual “matched” meetings could thrive and deals could get done. LSN is leading the way again with this special $250 ticket aimed at scientist-entrepreneurs and first-time fundraising CEOs. Many of these players lack a support system to help them navigate the move from academia to a commercial startup entity. In many instances, they underestimate the critical importance of sales, marketing, and business development even at an early stage, and lack a marketing budget putting conferences out of reach.

With the Audience Access Ticket, these companies gain live access to RESI’s numerous panels, workshops, and pitch sessions, allowing them to benefit from investors, industry experts and successful entrepreneurs providing insights that can help them understand what they need to make the best impression in their fundraising campaigns. In addition to the live access, users also get access to all recordings for an additional three weeks following the conference.

Dennis Ford, Founder and CEO of LSN states “Exposing the startup executives to the LSNs global network early on in the partnering process through an Audiences Access Ticket, will really flip a few switches on in their heads. They will be able to see firsthand how other entrepreneurs have successfully executed their global partnering campaigns.  Seeing is believing, and early stage entrepreneurs need to observe how other entrepreneurs prepare for events like RESIs Innovator’s Pitch Challenge and hear directly from scientist-entrepreneurs and fundraising CEOs in the Tales From The Road panels. LSN has been delivering a line-up of the who’s who of capital investors and licensing partners who participate on panels aimed at providing entrepreneurs with insight as to how they fill their investment mandates for portfolio companies and how Pharma business development executives source and license technology assets for their product pipelines.”

Candice He, LSN’s VP of Business Development says “Providing access to the 16 capital investor and licensing partner panels is exactly what is needed for these first-time entrepreneurs to cross the chasm and get serious about their partnering initiatives. LSN believes that we have an invaluable content resource that we need to share that and get the early stage executives immersed in the partnering marketplace.“

RESI is unique in that its main draw is its match-based partnering platform. Most other life science conferences use content as the lead draw and partnering secondary.  However that doesn’t change the fact that RESI content is also world class. Because RESI is a dedicated partnering event, its content is 100% partnering oriented, and all the panels and workshops revolve around investors and licensing partners educating entrepreneurs on how they source and evaluate, and their process of doing business with startups.  Plugging into this network, even at the earliest stages, allows companies to get a head start on learning who the key players are, and can help them more easily navigate their future partnering campaigns. Learn more about each content feature of the Audience Access pass and register today for a special $250 offer!

Digital RESI June 7-9, 2022 Agenda
	Tuesday (6/7)	Wednesday (6/8)	Thursday (6/9)
10AM EDT	IPC Session #1 Therapeutics	IPC Session #4 Therapeutics	IPC Session #8 AI (Devices & Digital Health)
11AM EDT	Beyond Big Pharma Partnering & Perspectives from Small and Mid-Sized Biotech	AI vs. Life Science Which Comes First in Early-Stage Investment?	Age-Tech Care Management Technology Improving the Lives of Older Adults
12PM EDT	Keeping Your Life Science Startup Out of the “Valley of Death”	Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?	SEEDing Biomedical Innovation: Support for Small Businesses at NIH
1PM EDT	Angel Investors Explaining the Process of Engagement	Corporate VC The Changing Landscape & New Opportunities	Impact Investors More Than Financial Returns
	IPC Session #2 Medical Devices	IPC Session #5 Medical Devices	IPC Session #9 Therapeutics and R&D Services
2PM EDT	The Neuroscience of Aging Aging Impact on the Nervous System	Asia Cross-Border Building Global Partnerships	Team, Tech, and Traction in Early-Stage AI Building Your Startup as a Triple Threat
3PM EDT	Fundraising Bootcamp	IPC Session #4 Therapeutics	Software-Enabled Medical Devices Investing at the Intersection of Digital Health and Medtech
4PM EDT	Tales from the Road: AI Innovation in Healthcare Standing Out in a Growing Field	Tales from the Road: Age-Related Diseases Developing Prevention & Treatments	Tales from the Road: Biotech and MedTech Innovators Entrepreneurs on Their Fundraising Journey
5PM EDT	IPC Session #3 Devices & Diagnostics	IPC Session #7 AI (Devices & Digital Health)	IPC Session #10 Therapeutics

By Rory McCann, Marketing Manager & Conference Producer, LSN

Funding in early-stage life science and healthcare has been booming throughout the Covid-19 pandemic, but as we face inflation and a potential economic downturn, the future is not as clear. RESI is much more than a partnering conference in that it also offers value and insight from experts in a variety of formats, one such being panels. RESI panels are primarily run by investors discussing the latest trends and forecasting for specific investment types or sub-sectors. Additionally, RESI offers Tales from the Road panels, which are informal discussions from early-stage entrepreneurs about their fundraising journeys, offering advice and sharing experiences.

Check out the latest panelist lineup from Digital RESI, June 7-9. Sign up to hear from each speaker on their outlooks and best practices while navigating partnerships, deals, and building strong startups.

Tuesday, June 7

11 AM EDT – Beyond Big Pharma
Partnering & Perspectives from Small & Mid-Sized Biotech

Kevin Lin Director, Business Development Transcenta Holding	Sa’ar Yaniv Director, Business Development Fortress Biotech	Rachel Zolot Schwartz, MBA (Moderator) Vice President & Head, Business Development & Commercial, Volastra

1 PM EDT – Angel Investors
Explaining the Process of Engagement

Ozan Isinak, MBA President, Central Canada Keiretsu Forum	Kristin King Member Boston Harbor Angels	Yaniv Sneor Founding Member Mid Atlantic Bio Angels

Eran Steinberg President & Chairman Vaica	Tom Vogelsong, PhD Director, Deal Flow KYTO Technology & Life Science

2 PM EDT – The Neuroscience of Aging
Aging Impact on the Nervous System

Mylea Charvat Founder & CEO Savonix	James Mayer Senior Manager, Investment & Venture Services Centre for Aging & Brain Health Innovation (CABHI)	Diana Saraceni Founder & Managing Partner Panakes Partners

Lu Zhang Founder & Managing Partner Fusion Fund

4 PM EDT – Tales from the Road: AI Innovation in Healthcare
Standing Out in a Growing Field

Kaitlin Christine Founder & CEO Gabbi	Rory McCann (Moderator) Conference Producer Life Science Nation	Maria Luisa Pineda, PhD Founder & CEO Envisagenics

Vangelis Vergetis, PhD Co-Founder & Executive Director Intelligencia

Wednesday, June 8

11 AM EDT – AI vs. Life Science
Which Comes First in Early-Stage Investment?

Ming Cheah, PhD Principal Pivotal bioVenture Partners	Marina Cortes Venture Partner SandBanks Capital	Baudouin Hue Partner Karista

Bill Kuziel (Moderator) Analyst & Investor MedPro Investors

1 PM EDT – Corporate VC
The Changing Landscape & New Opportunities

Michael Baran Executive Director, WRD & Principal Pfizer Ventures	Lana Ghanem Managing Director Hikma Ventures	David Gordon Head, Investments Longliv Ventures

Jane Rho Investor DaVita Venture Group	Cheryl Zimberlin Investment Director M Ventures

2 PM EDT – Asia Cross-Border
Building Global Partnerships

Tai Harada Vice President Fast Track Initiative	Seo Lee Director SV Investment	Cindy Liu Vice President Qiming Venture Partners

Derek Yuan Principal LYFE Capital

4 PM EDT – Tales from the Road: Age-Related Diseases
Developing Prevention & Treatments

Anthony DePasqua President EnClear Therapeutics	Robin Mansukhani CEO Deciduous Therapeutics	Eric Levitan  Founder & CEO Vivo

Thursday, June 9

11 AM EDT – Age-Tech Care Management
Technology Improving the Lives of Older Adults

Anastasiya Giarletta Principal R42 Group	Sarah Hippert Program Manager Techstars	Brenda Hogan (Moderator) Chief Investment Officer Ontario Capital Growth Corporation (OCGC)

Lise Pape Founder Walk with Path

1 PM EDT – Impact Investors
More Than Financial Returns

André Harrell Venture Partner Cancer Fund	Richard Lipkin Co-Founder & Co-Chair The Catalytic Impact Foundation	Ben Nahir Venture Principal Elevate Capital

John Parker (Moderator) Founder & Managing Director Springhood Impact Ventures

2 PM EDT – Team, Tech, & Traction in Early-Stage AI
Building Your Startup as a Triple Threat

Sebastien Latapie Principal Dynamk Capital	Gayathri Radhakrishnan, MBA Senior Director Venture Capital – AI Fund Micron Ventures	Surbhi Sarna Group Partner Y Combinator

Alex Zhavoronkov, PhD (Moderator) CEO InSilico Medicine

3 PM EDT – Software-Enabled Medical Devices
Investing at the Intersection of Digital Health and Medtech

Chris Bostick Partner OCV Partners	Lana Caron Innovation Lead Philips Health Technology Ventures	James Hardiman Partner Data Collective (DCVC Bio)

Katherine Relle, MBA Vice President Accelmed

4 PM EDT – Tales from the Road: Biotech and MedTech Innovators
Entrepreneurs on Their Fundraising Journey

Sven Henrichwark, PhD CEO Fibronostics	David Sherris, PhD CEO Penrose TherapeuTx

By Alexander Vassallo, Manager of Business Development West Coast (US), LSN

For innovative startups in life science and healthcare, the early days feel like the sky is the limit. But what if it wasn’t? Care in Space is a newly launched initiative supporting the development and commercialization of technologies and solutions that will support long-term habitation and travel in space and/or utilize microgravity to manufacture new or more effective therapeutics. This first-of-its-kind program leverages the extreme conditions of space to not only drive innovation but to build viable businesses at the intersection of commercial space and biomedical science.  

For over a decade, Life Science Nation (LSN) has connected entrepreneurs with early-stage capital and licensing via events, products, and services designed specifically for them, and this program is offering a great opportunity for well-matched startups. 

Description: A challenge to find novel solutions and technologies that support human health in space and/or are manufactured in space to support health on Earth. Challenge winners (8-10 companies) will participate in a 13-week program culminating with a Demo Day.

Focus areas: Biological and technological solutions that support our ability to live in and travel long distances through space; from regenerative medicine (cellular protection & repair, radiation & aging research, stem cell therapy, 3D bioprinting) to pharma (drug discovery and manufacturing) to synthetic bio (new medicines, modified foods, gene therapy, nutritional therapy) to wearables (health monitoring, medical devices, AI assisted diagnosis) to precision medicine (big data, genomics, AI/ML).

Who should apply: Global pre-seed and seed stage companies

Terms: The winning teams will receive $100,000+ each in prize funding and on-orbit research support, in exchange for equity.

Key dates:

• Applications: April 18 – June 17
• CIS Challenge Pitch Day: July 28
• Program dates: September 12 – December 9
• Demo Day: December 8

The program is looking for solutions with space and terrestrial application, with strong scientific merit, business model viability, and overall feasibility. If you believe your technology could be viable for the Care in Space program, follow this link to apply.